Universe's 15-minute chart triggers KDJ Golden Cross, bullish Marubozu pattern emerges.
PorAinvest
lunes, 13 de octubre de 2025, 10:17 am ET1 min de lectura
GLTO--
Galecto Inc. experienced the largest increase in momentum, rising from a score of 9.3 to 96.64. The stock is trading far above its 50-day moving average, currently at $15.70 compared to the 50-day average of $3.77 [1].
Xenetic Biosciences Inc. saw a momentum gain of 75.56 points, rising from 21.97 to 97.53. The stock is also trading above its 50-day moving average, currently at $9.70 compared to the 50-day average of $3.23 [1].
Universe Pharmaceuticals Inc. had the third largest increase in momentum score, rising from 12.95 to 82.24. The stock is trading above its 50-day moving average, currently at $6.40 compared to the 50-day average of $4.02 [1].
Alaunos Therapeutics, Inc. rounds out the list, gaining 68.77 points since last week to rise from 15.88 to 84.65. The stock is trading above its 50-day moving average, currently at $3.95 compared to the 50-day average of $2.43 [1].
Price action on Thursday saw Galecto stock trading 28.27% higher at $13.85, Xenetic shares trading 9.27% lower at $9.40, Universe shares trading 33.30% lower at $6.31, and Alaunos shares trading 6.49% higher at $3.96 [1].
In addition to these momentum shifts, Universe Pharmaceuticals has recently exhibited a KDJ Golden Cross on its 15-minute chart, accompanied by a Bullish Marubozu at 10:15 on October 13, 2025. This suggests that the stock price is trending upwards and has the potential to continue increasing as buyers maintain control of the market [1].
Investors should monitor these stocks closely for further developments. As always, it is important to conduct thorough research and consider seeking professional financial advice before making investment decisions.
TCRT--
UPC--
XBIO--
The 15-minute chart for Universe has recently exhibited a KDJ Golden Cross, accompanied by a Bullish Marubozu at 10:15 on October 13, 2025. This shift in momentum suggests that the stock price is trending upwards and has the potential to continue increasing. As buyers maintain control of the market, bullish momentum is likely to persist.
Healthcare and biotech stocks have been lagging behind broader markets this year, but a growing number of names are showing signs of picking up momentum. According to Benzinga's Edge Stock Rankings system, four biotech stocks have posted significant increases in bullish momentum over the past week. These stocks, Galecto Inc. (GLTO), Xenetic Biosciences Inc. (XBIO), Universe Pharmaceuticals Inc. (UPC), and Alaunos Therapeutics, Inc. (TCRT), are leading the charge with impressive gains.Galecto Inc. experienced the largest increase in momentum, rising from a score of 9.3 to 96.64. The stock is trading far above its 50-day moving average, currently at $15.70 compared to the 50-day average of $3.77 [1].
Xenetic Biosciences Inc. saw a momentum gain of 75.56 points, rising from 21.97 to 97.53. The stock is also trading above its 50-day moving average, currently at $9.70 compared to the 50-day average of $3.23 [1].
Universe Pharmaceuticals Inc. had the third largest increase in momentum score, rising from 12.95 to 82.24. The stock is trading above its 50-day moving average, currently at $6.40 compared to the 50-day average of $4.02 [1].
Alaunos Therapeutics, Inc. rounds out the list, gaining 68.77 points since last week to rise from 15.88 to 84.65. The stock is trading above its 50-day moving average, currently at $3.95 compared to the 50-day average of $2.43 [1].
Price action on Thursday saw Galecto stock trading 28.27% higher at $13.85, Xenetic shares trading 9.27% lower at $9.40, Universe shares trading 33.30% lower at $6.31, and Alaunos shares trading 6.49% higher at $3.96 [1].
In addition to these momentum shifts, Universe Pharmaceuticals has recently exhibited a KDJ Golden Cross on its 15-minute chart, accompanied by a Bullish Marubozu at 10:15 on October 13, 2025. This suggests that the stock price is trending upwards and has the potential to continue increasing as buyers maintain control of the market [1].
Investors should monitor these stocks closely for further developments. As always, it is important to conduct thorough research and consider seeking professional financial advice before making investment decisions.
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios